Research and analysis: COVID-19: PHE laboratory assessments of molecular tests
PHE has undertaken rapid assessments of commercially provided diagnostic tests for SARS-CoV-2 nucleic acid detection with further evaluations ongoing.
PHE has undertaken rapid assessments of commercially provided diagnostic tests for SARS-CoV-2 nucleic acid detection with further evaluations ongoing.
Reference-only version of letter from the government to people who are clinically extremely vulnerable.
Information for pregnant women to understand what it means to be an alpha zero thalassaemia carrier.